CHF50.20
0.08% today
SIX Swiss Exchange, Sep 01, 05:30 pm CET
ISIN
CH1243598427
Symbol
SDZ
Index

Sandoz Stock price

CHF50.20
+3.47 7.43% 1M
+10.45 26.29% 6M
+13.03 35.06% YTD
+13.45 36.60% 1Y
+20.70 70.17% 3Y
+20.70 70.17% 5Y
+20.70 70.17% 10Y
+20.70 70.17% 20Y
SIX Swiss Exchange, Closing price Mon, Sep 01 2025
+0.04 0.08%
ISIN
CH1243598427
Symbol
SDZ
Index
Industry

Key metrics

Basic
Market capitalization
CHF22.2b
Enterprise Value
CHF25.6b
Net debt
CHF3.4b
Cash
CHF1.1b
Shares outstanding
430.7m
Valuation (TTM | estimate)
P/E
122.3 | 19.0
P/S
2.6 | 2.5
EV/Sales
3.0 | 2.9
EV/FCF
-
P/B
3.1
Dividends
DPS
CHF0.60
Yield 1Y | 5Y
1.2% | 0.7%
Growth 1Y | 5Y
33.3% | -
Payout 1Y | 3Y
- | 61.1%
Increased
2 Years
Financials (TTM | estimate)
Revenue
CHF8.5b | CHF8.9b
EBITDA
- | CHF1.8b
EBIT
CHF1.4b | CHF1.6b
Net Income
CHF181.7m | CHF1.1b
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
- | 6.8%
EBITDA
- | 9.5%
EBIT
- | 22.2%
Net Income
- | -
Free Cash Flow
-
Margin (TTM | estimate)
Gross
47.8%
EBITDA
- | 20.6%
EBIT
16.4%
Net
2.1% | 12.8%
Free Cash Flow
-
Financial Health
Equity Ratio
41.0%
Return on Equity
0.0%
ROCE
11.5%
ROIC
9.8%
Debt/Equity
0.6
More
EPS
CHF0.4
FCF per Share
-
Short interest
-
Employees
20k
Rev per Employee
CHF420.0k
Show more

Is Sandoz a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Sandoz Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Sandoz forecast:

13x Buy
72%
5x Hold
28%

Analyst Opinions

18 Analysts have issued a Sandoz forecast:

Buy
72%
Hold
28%

Financial data from Sandoz

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
8,475 8,475
-
100%
- Direct Costs 4,421 4,421
-
52%
4,054 4,054
-
48%
- Selling and Administrative Expenses 1,888 1,888
-
22%
- Research and Development Expense 756 756
-
9%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 1,392 1,392
-
16%
Net Profit 182 182
-
2%

In millions CHF.

Don't miss a Thing! We will send you all news about Sandoz directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sandoz Stock News

marktEINBLICKE
2 days ago
Der Generika-Hersteller konnte zuletzt immer wieder mit mit positiven Nachrichten aufwarten und auch aus Sicht der Point & Figure Charttechnik kaufenswert.
AD HOC NEWS
3 months ago
Der Pharmakonzern Sandoz CH1243598427 hat den Marktstart von zwei neuen Biosimilars in den USA bekannt gegeben.

Company Profile

Sandoz Group AG engages in focusing on generic pharmaceuticals and bio similar medical products. It acquires, manages and sells investments and intellectual property in the healthcare and medical device industry and conducts all business at home and abroad. The firm can acquire, sell, debit and manage interests in other companies, intellectual property rights and real estate at home and abroad, as well as establish branches and subsidiaries at home and abroad. The company was founded on January 17, 2022 and is headquartered in Rotkreuz, Switzerland.

Head office Switzerland
CEO Mr. Saynor
Employees 20,000
Founded 2022
Website www.sandoz.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today